Brief introduction of current technologies in isolation of broadly neutralizing HIV-1 antibodies

HIV/AIDS has become a worldwide pandemic. Before an effective HIV-1 vaccine eliciting broadly neutralizing monoclonal antibodies (bnmAbs) is fully developed, passive immunization for prevention and treatment of HIV-1 infection may alleviate the burden caused by the pandemic. Among HIV-1 infected ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Zehua, Yan, Lixin, Tang, Jiansong, Qian, Qian, Lenberg, Jerica, Zhu, Dandan, Liu, Wan, Wu, Kao, Wang, Yilin, Lu, Shiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114535/
https://www.ncbi.nlm.nih.gov/pubmed/29051051
http://dx.doi.org/10.1016/j.virusres.2017.10.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114535/
https://www.ncbi.nlm.nih.gov/pubmed/29051051
http://dx.doi.org/10.1016/j.virusres.2017.10.011

Ejemplares similares